Related Experiment Video
Updated: Nov 26, 2025

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
Amal El Ouarradi1, Salma Abdeladim1, Sara Oualim1
1Department of Cardiology, Mohammed VI University of Health Sciences, Cheikh Khalifa Hospital, Casablanca, Morocco.
The combination of hydroxychloroquine and azithromycin in COVID-19 patients can cause QT interval prolongation, a significant cardiac side effect. Close ECG monitoring is crucial, especially for high-risk individuals, to prevent severe rhythm disturbances.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- The COVID-19 pandemic spurred interest in hydroxychloroquine and azithromycin treatments.
- This combination therapy raised concerns regarding potential severe cardiac side effects.
Purpose of the Study:
- To evaluate the cardiovascular effects of combined hydroxychloroquine and azithromycin in COVID-19 patients.
- To analyze surface electrocardiogram (ECG) changes associated with this treatment regimen.
Main Methods:
- An observational cohort study involving 118 hospitalized COVID-19 patients in Morocco.
- Patients received a minimum ten-day course of hydroxychloroquine and azithromycin.
- Surface ECGs were analyzed to assess cardiac effects, focusing on QT interval prolongation.
Main Results:
- QT interval prolongation was observed in 19% of patients.
- Factors associated with QT prolongation included male gender, age over 68, cardiovascular comorbidity, high Tisdale score, and severe COVID-19.
- First-degree atrioventricular block occurred in 2 patients; no serious rhythm disorders were noted.
Conclusions:
- QT interval prolongation is a significant risk associated with the hydroxychloroquine and azithromycin combination in COVID-19 patients.
- Patient selection and close ECG monitoring are essential to identify individuals at high risk for cardiac rhythm disturbances.
- Discontinuation of treatment is advised for alarming signs like QTc prolongation (>550 ms) or ventricular arrhythmias.
Related Concept Videos
Myocarditis III: Medical Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...

